Urinary epidermal growth factor

Danish Medical Bulletin

Volumn 44, Issue 2, 1997, Pages 111-124

  Jørgensen, Per E ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR;

CHEMICAL STRUCTURE; HUMAN; MOLECULAR BIOLOGY; MOLECULAR WEIGHT; NONHUMAN; PROTEIN ANALYSIS; PROTEIN PROCESSING; QUANTITATIVE ASSAY; REVIEW; URINALYSIS;

EID: 0030984899     PISSN: 09078916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (204)

1. Jørgensen PE, Poulsen SS, Nexø E. Distribution of i.v. administered epidermal growth factor in the rat. Regul Pept 1988; 23: 161-169.
2. Jørgensen PE, Nexø E, Raaberg L, Rasmussen TN, Poulsen SS. Metabolism of i.v. administered 45 kDa epidermal growth factor in the rat. Regul Pept 1990; 30: 113-123.
3. Jørgensen PE, Raaberg L, Poulsen SS, Nexø E. The urinary excretion of epidermal growth factor in the rat is reduced by aprotinin, a proteinase inhibitor. Regul Pept 1990; 31: 115-124.
4. Jørgensen PE, Rasmussen TN, Olsen PS, Raaberg L, Poulsen SS, Nexø E. Renal uptake and excretion of epidermal growth factor from plasma in the rat. Regul Pept 1990; 28: 273-281.
5. Nexø E, Jørgensen PE, Thim L, Roepstorff P. Purification and characterization of a low and a high molecular weight form of epidermal growth factor from rat urine. Biochim Biophys Acta 1990; 1037: 388-393.
6. Jørgensen PE, Nexø E, Poulsen SS. The membrane fraction of homogenized rat kidney contains an enzyme that releases epidermal growth factor from the kidney membranes. Biochim Biophys Acta 1991; 1074: 284-288.
7. Jørgensen PE, Hilchey SD, Nexø E, Poulsen SS, Quilley CP. Urinary epidermal growth factor is excreted from the rat isolated perfused kidney in the absence of plasma. J Endocrinol 1993; 139: 227-234.
8. + on urinary excretion of epidermal growth factor in the rat. Regul Pept 1993; 44: 17-24.
9. Jørgensen PE, Nexø E, Poulsen SS, Almendingen M, Berg T, Processing of epidermal growth factor in the rat submandibular gland by kallikrein-like enzymes. Growth Factors 1994; 11: 113-123.
10. Jørgensen PE, Kamper A-L, Munck O, Strandgaard S, Nexø E. Urinary excretion of epidermal growth factor in living human kidney donors and their recipients. Eur J Clin Invest 1995; 25: 442-446.
11. Jørgensen PE, Vinter-Jensen L, Nexø E. An immunoassay designed to quantitate different molecular weight forms of urinary EGF with equimolar potency: application on fresh rat urine. Scand J Clin Lab Invest 1996; 56: 25-36.
12. Amado JA, De-Francisco AL, Botana MA, Pesquera C, Vázquez-de-Prada JA, Arias M. Influence of kidney or heart transplantation on the urinary excretion of epidermal growth factor. Transpl Int 1994; 7: 127-130.
13. Ambs KE, Takahashi A, Hering F, Costa S, Huber PR. Epidermal growth factor receptor in adenocarcinoma of the kidney. Urol Res 1989; 17: 251-254.
14. Araki F, Nakamura H, Nojima N, Tsukumo K, Sakamoto S. Stability of recombinant human epidermal growth factor in various solutions. Chem Pharm Bull 1989; 37: 404-406.
15. Atkin BM, Franklin WA, Bell GI, Toback FG. Macula densa cells of mouse kidney do not synthesize epidermal growth factor precursor mRNA. Nephron 1990; 54: 313-317.
16. Atlas I, Mendelsohn J, Baselga J, Fair WR, Masui H, Kumar R. Growth regulation of human renal carcinoma cells: role of transforming growth factor α. Cancer Res 1992; 52: 3335-3339.
17. Avner ED, Sweeney WE. Epidermal growth factor receptor (EGFR). but not NaKATPase, is mislocated to apical cell surfaces of collecting tubule cysts in human autosomal recessive polycystic kidney disease (ARPKD). J Am Soc Nephr 1992; 3: 292 (abstr).
18. Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller Jr WH, Mendelsohn J. Antitumor effects of doxorubicin in combination with antiepidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 1993; 85: 1327-1333.
19. Behrens MT, Corbin AL, Hise MK. Epidermal growth factor receptor regulation in rat kidney: two models of renal growth. Am J Physiol 1989; 257: F1059-F1064.
20. Bell GI, Fong NM, Stempien MM, Wormsted MA, Caput D, Ku L, Urdea MS, Rall LB, Sanchez-Pescador R. Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucl Acid Res 1986; 14: 8427-8446.
21. Ben-Ezra J, Sheibani K, Hwang DL, Lev-Ran A. Megakaryocyte synthesis is the source of epidermal growth factor in human platelets. Am J Pathol 1990; 137: 755-759.
22. Berg T, Bradshaw RA, Carretero OA, Chao J, Chao L, Clements JA, Fahnestock M, Fritz H, Gauthier F, Macdonald RJ, Margolius HS, Morris BJ, Richards RI, Scicli AG. A common nomenclature for members of the tissue (glandular) kallikrein gene families. Agents Actions Suppl 1992; 38/I: 19-25.
23. Berg T, Hoick M, Johansen L. Isolation, characterization, and localization of antigen γ. a serine proteinase of the "kallikrein-family" in the rat submandibular gland. Biol Chem Hoppe-Seyler 1987; 368: 1455-1467.
24. Berg T, Schøyen H, Wassdal I, Hull R, Gerskowitch VP, Toft K. Characterization of a new kallikrein-like enzyme (KLP-S3) of the rat submandibular gland. Biochem J 1992; 281: 819-828.
25. Berg T, Wassdal I, Mindroiu T, Sletten K, Scicli G, Carretero OA, Scicli AG. T-kininogenase activity of the rat submandibular gland is predominantly due to the kallikrein-like serine protease antigen γ. Biochem J 1991; 280: 19-25.
26. Berg T, Wassdal I, Sletten K. Immunohistochemical localization of rat submandibular gland esterase B (homologous to the RSKG-7 kallikrein gene) in relation to other serine proteases of the kallikrein family. J Histochem Cytochem 1992; 40: 83-92.
27. Bjerke T, Nielsen S, Hellfritzsch M, Christensen EI, Nexø E. Renal tubular handling of epidermal growth factor in rat and rabbit. Contr Nephrol 1988; 68: 98-103.
28. Breyer J, Harris R. EGF binds to specific EGF receptors and stimulates mitogenesis in renal medullary interstitial cells. Kidney Int 1988; 33: 255 (abstr).
29. Breyer JA, Cohen S. The epidermal growth factor precursor isolated from murine kidney membranes, chemical characterization and biological properties. J Biol Chem 1990; 265: 16564-16570.
30. Breyer MD, Jacobson HR, Breyer JA. Epidermal growth factor inhibits the hydroosmotic effect of vasopressin in the isolated perfused rabbit cortical collecting tubule. J Clin Invest 1988; 82: 1313-1320.
31. Brown GL, Curtsinger L, Jurkiewicz MJ, Nahai F, Schultz G. Stimulation of healing of chronic wounds by epidermal growth factor. Plast Reconstr Surg 1991; 88: 189-194.
32. Brown GL, Nanney LB, Griffen J, Cramer AB, Yancey JM, Curtsinger LJ, Holtzin L, Schuitz GS, Jurkiewicz MJ, Lynch JB. Enhancement of wound healing by topical treatment w ith epidermal growth factor. N Eng J Med 1989; 321: 76-79.
33. Burgess AW, Lloyd CJ, Smith S, Stanley E, Walker F, Fabri L, Simpson RJ, Nice EC. Murine epidermal growth factor: structure and function. Biochemistry 1988; 27: 4977-4985.
34. Byyny RL, Orth DN, Cohen S. Radioimmunoassay of epidermal growth factor. Endocrinology 1972; 90: 1261-1266.
35. Byyny RL, Orth DN, Cohen S, Doyne E. Epidermal growth factor: effects of androgens and adrenergic agents. Endocrinology 1974; 95: 776-782.
36. Callegari C, Laborde NP, Buenaflor G, Nascimento CG, Brasel JA, Fisher DA. The source of urinary epidermal growth factor in humans. Eur J Apll Physiol 1988; 58: 26-31.
37. Carpenter G, Wahl MI. The epidermal growth factor family. In Sporn MB, Roberts AB (Eds). Peptide growth factors and their receptors. Handbook of experimental pharmacology. Springer Verlag, Berlin 1990; 95/I: 69-171.
38. Cellini M, Baldi A, Caramazza N, De Felice GP, Gazzaniga A. Epidermal growth factor in the topical treatment of herpetic corneal ulcers. Ophthalmologica 1994; 208: 37-40.
39. Chow NH, Tzai T-S,Cheng P-E, Chang C-J, Lin JS-N, Tang M-J. An assessment of immunoreactive epidermal growth factor in urine of patients with urological diseases. Urol Res 1994; 22: 221-225.
40. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eylid opening in the new-born animal. J Biol chem 1962; 237: 1555-1562.
41. Cohen S, Fava RA, Sawyer ST. Purification and characterization of epidermal growth factor receptor/protein kinase from normal mouse liver. Proc natl Acad Sci USA 1982; 79: 6237-6241.
42. Coimbra TM, Cieslinski DA, Humes HD. Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. Am J Physiol 1990; 259: F438-F443.
43. 125I-EGF to cell surface receptors, a useful artifact of chloramine-T treatment. J Biol Chem 1982; 257: 42-45.
44. 131I-labeled epidermal growth factor and its ditribution in rat tissues. Eur J Biochem 1972; 27: 225-230.
45. Dagogo-Jack S, Marshall SM, Kendall-Taylor P, Alberti KGMM. Urinary excretion of human epidermal growth factor in the various stages of diabetic nephropathy. Clin Endocrinol 1989; 31: 167-173.
46. Davison JM, Uldall PR, Walls J. Renal function studies after nephrectomy in renal donors. Br Med J 1976; 1: 1050-1052.
47. Derynck R. The physiology of transforming growth factor-α. Advances Cancer Res 1992; 58: 27-52.
48. Di Marco E, Pierce JH, Aaronson SA, Di Fiore PP. Mechanisms by which EGF receptor and TGFα contribute to malignant transformation. Nat Immun Cell Growth Regul 1990; 9: 209-221.
49. Dubeau L, Jones PA. Growth of normal and neoplastic urothelium and response to epidermal growth factor in a defined serum-free medium. Cancer Res 1987; 47: 2107-2112.
50. Elder JB, Kiff ES, Gregory H. Half-life of urogastrone in conscious dogs. Gut 1978; 19: A436 (abstr).
51. Engelman RW, Owens UE, Bradley WG, Day NK, Good RA. Mammary and submandibular gland epidermal growth factor expression is reduced by calorie restriction. Cancer Res 1995; 55: 1289-1295.
52. Fantl WJ, Johnson DE, Williams LT. Signalling by receptor tyrosine kinases. Annu Rev Biochem 1993; 62: 453-481.
53. Fritz H, Wunderer G. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneim-Forsch/Drug res 1983; 33(I): 479-494.
54. Fuse H, Mizuno I, Sakamoto M, Katayama T. Epidermal growth factor in urine from patients with urothelial tumors. Urol Int 1992; 48: 261-264.
55. George-Nascimento C, Gyenes A, Halloran SM, Merryweather J, Valenzuela P, Steimer KS, Masiarz FR, Randolph A. Characterization of recombinant human epidermal growth factor produced in yeast. Biochemistry 1988: 27: 797-802.
56. Goodyer PR, Kachra Z, Bell C, Rozen R. Renal tubular cells are potential targets for epidermal growth factor. Am J Physiol 1988; 255: F1191-F1196.
57. Gow CB, Phillips PA, Chandler KD, Moore GPM. Hormonal, fluid, and electrolyte responses of sheep during chronic intravenous infusion of epidermal growth factor. Am J Physiol 1993; 265: R203-R210.
58. Gray A, Dull TJ, Ullrich A. Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor. Nature 1983; 303: 722-725.
59. Gregory H. Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 1975; 257: 325-327.
60. Gregory H, Holmes JE, Willshire IR. Urogastrone levels in the urine of normal adult humans. J Clin Endocrinol Metab 1977; 45: 668-672.
61. Gresik EW. The granular convoluted lubule (GCT) cell of rodent submandibular glands. Microscopy Res Tech 1994; 27: 1-24.
62. Gung A, Badr KF, Orth DN, Harris RC. Effect of dietary protein and uninephrectomy (Unx) on urinary epidermal growth factor excretion (uEGF). Kidney Int 1988: 33: 376 (abstr).
63. Harris RC. Response of rat inner medullary collecting duct to epidermal growth factor. Am J Physiol 1989; 256: F1117-F1124.
64. Harris RC, Daniel TO. Epidermal growth factor binding, stimulation of phosphorylation, and inhibition of gluconeogenesis in rat proximal tubule. J Cell Physiol 1989; 139: 383-391.
65. Harris RC, Hoover RL, Jacobson HR, Badr KF. Evidence for glomerular actions of epidermal growth factor in the rat. J Clin Invest 1988; 82: 1028-1039.
66. Hayashi T, Sakamoto S. Radioimmunoassay of human epidermal growth factor-hEGF levels in human body fluids. J Pharmacobio-Dyn 1988; 11 : 146-151.
67. Helin K, Velu T, Martin P, Vass WC, Allevato G, Lowy DR, Beguinot L. The biological activity of the human epidermal growth factor receptor is positively regulated by its C-terminal tyrosines. Oncogene 1991; 6, 825-832.
68. Hernández-Sotomayor SMT, Carpenter G. Epidermal growth factor receptor: elements of intracellular communication. J Membrane Biol 1992; 128: 81-89.
69. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991; 251: 936-939.
70. Hirata Y, Orth DN. Epidermal growth factor (urogastrone) in human fluids: size heterogeneity. J Clin Endocrinol Metab 1979; 48: 673-679.
71. Hirata Y, Uchihashi M, Nakajima M, Fujita T, Matsukura S. Immunoreactive human epidermal growth factor in human pancreatic juice. J Clin Endocrinol Metab 1982; 54: 1242-1245.
72. Humes HD, Cieslinski DA, Coimbra TM, Messana JM, Galvao C. Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 1989; 84: 1757-1761.
73. Hwang DL, Lev-Ran A. Infusion of epidermal growth factor in mice: organ distribution and urinary excretion. Regul Pept 1990; 29: 103-108.
74. Ishikawa J, Maeda S, Sugiyama T, Nishimura R, Mizoguchi A, Kamidono S. EGF stimulates anchorage-independent growth of a human bladder carcinoma cell line (KU1) with an amplified and over-expressed EGF receptor gene. Int J Cancer 1989; 44: 1000-1004.
75. Ishikawa J, Maeda S, Umezu K, Sugiyama T, Kamidono S. Amplification and overexpression of the epidermal growth factor receptor gene in human renal-cell carcinoma. Int J Cancer 1990; 45: 1018-1021.
76. Jennische E, Andersson G, Hansson H-A. Epidermal growth factor is expressed by cells in the distal tubules during postnephrectomy renal growth. Acta physiol Scand 1987; 129: 449-450.
77. Joh T, Itoh M, Yasue N, Miyamoto T, Iwai A, Matsusako K, Endoh K, Takeuchi T, Moriyama A, Kato T, Tanaka R. A sensitive enzyme immunoassay system of rat epidermal growth factor in biological fluids and tissue extracts. Acta Endocrinol 1989; 120: 616-623.
78. Kamada M, Furuhata N, Yamaguchi T, Ikekita M, Kizuki K, Moriya H. Observation of tissue prokallikrein activation by some serine proteases, arginine esterases in rat submandibular gland. Biochem Biophys Res Commun 1990; 166: 231-237.
79. Kanda S, Nomata K, Saha PK, Nishimura N, Yamada J, Kanatake H, Saito Y. Growth factor regulation of the renal cortical tubular cells by epidermal growth factor, insulin-like growth factor-I, acidic and basic fibroblast growth factor, and transforming growth factor-β in serum free culture. Cell Biol Int Rep 1989; 13: 687-699.
80. Kanda S, Saha PK, Nomata K, Taide M, Nishimura N, Igawa T, Yamada J, Kanetake H, Saito Y. Transient increase in renal epidermal growth factor content after unilateral nephrectomy in the mouse. Acta Endocrinol 1991; 124: 188-193.
81. Kashimata M, Hiramatsu M, Minami N, Minami N. Biochemical properties of epidermal growth factor in the mouse kidney. Comp Biochem Physiol 1987; 86B: 651-653.
82. Khullar M, Scicli G, Carretero OA, Scicli AG. Purification and characterization of a serine protease (esterase B) from rat submandibular glands. Biochemistry 1986; 25: 1851-1857.
83. Kienhuis CBM, Heuvel JJTM, Ross HA, Swinkels LMJW, Foekens JA, Benraad TJ. Six methods for direct radioiodination of mouse epidermal growth factor compared: effect of non-equivalence in binding behavior between labeled and unlabeled ligand. Clin Chem 1991; 37: 1749-1755.
84. Kim DC, Hanano M, Kanai Y, Ohnuma N, Sugiyama Y. Localization of binding sites for epidermal growth factor (EGF) in rat kidney: evidence for the existence of low affinity EGF binding sites on the brush boarder membrane. Pharm Res 1992; 9: 1394-1401.
85. Kim DC, Hanano M, Sawada Y, Iga T, Sugiyama Y. Kinetic analysis of clearance of epidermal growth factor in isolated perfused rat kidney. Am J Physiol 1991; 261: F988-F997.
86. Kim DC, Sugiyama Y, Satoh H, Fuwa T, Iga T, Hanano M. Kinetic analysis of in vivo receptor-dependent binding of human epidermal growth factor by rat tissues. J Pharm Sci 1988; 77: 200-207.
87. Kim D-C, Sugiyama Y, Sawada Y, Hanano M. Renal tubular handling of p-amino-hippurate and epidermal growth factor (EGF) in filtering and non-filtering perfused rat kidneys. Pharm Res 1992; 9: 271-275.
88. Kirkegaard P, Olsen PS, Poulsen SS, Nexø E. Exocrine secretion of epidermal growth factor from Brunner's glands. Stimulation by VIP and acetylcholine. Regul Pept 1983; 7: 367-372.
89. Krieger DT, Hauser H, Liotta A, Zelenetz A. Circadian periodicity of epidermal growth factor and its abolition by superior cervical ganglionectomy. Endocrinology 1976; 99: 1589-1596.
90. Kristensen JK, Lose G, Lund F, Nexø E. Epidermal growth factor in urine from patients with urinary bladder tumors. Eur Urol 1988; 14: 313-314.
91. Kuo B-S, Kusmik WF, Poole JC, Elsea SH, Chang J, Hwang K-K. Pharmacokinetic evaluation of two human epidermal growth factors (hEGF51 and hEGF53) in rats. Drug Metab Diposition 1992; 20: 23-30.
92. Kurachi H, Oka T. Changes in epidermal growth factor concentrations of submandibular gland, plasma and urine of normal and sialoadenectomized female mice during various reproductive stages. J Endocrinol 1985; 106: 197-202.
93. Lakshmanan J, salido EC, Lam R, Barajas L, Fisher DA. Identification of pro-epidermal growth factor and high molecular weight epidermal growth factors in adult mouse urine. Biochem Biophys Res Commun 1990; 173: 902-911.
94. Lakshmanan J, Salido EC, Lam R, Fisher DA. Epidermal growth factor prohormone is secreted in human urine. Am J Physiol 1992; 263: E142-E150.
95. Lee DC, Rose TM, Webb NR, Todaro GJ. Cloning and sequence analysis of a cDNA for rat transforming growth factor-α. Nature 1985; 313: 489-491.
96. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995; 267:1782-1788.
97. 13II]-human EGF and kidney histochemistry. Clin Exp Pharm Physiol 1992; 19: 667-673.
98. Lowden DA, Lindemann GW, Merlino G, Barash BD, Calvet JP, Gattone II VH. Renal cysts in transgenic mice expressing transforming growth factor-α. J Lab Clin Med 1994; 124: 386-394.
99. MacDonald RJ, Margolius HS, Erdös EG. Molecular biology of tissue kallikrein. Biochem J 1988; 253: 313-321.
100. 125I-epidermal growth factor purified by isoelectric focusing. Biochem Biophys Res Commun 1982; 108: 299-306.
101. Marti U, Burwen SJ, Barker ME, Huling S, Feren AM, Jones AL. Effect of oxidative iodination of epidermal growth factor on its binding and secretion by hepatocytes. J Cell Biochem 1989; 40: 109-119.
102. Mathiesen ER, Nexø E, Hommel E, Parving H-H. Reduced urinary excretion of epidermal growth factor in incipient and overt diabetic nephropathy. Diabetic Med 1989; 6: 121-126.
103. Manila A-L, Pasternack A, Viinikka L, Perheentupa J. Subnormal concentrations of urinary epidermal growth factor in patients with kidney disease. J Clin Endocrinol Metab 1986; 62: 1180-1183.
104. Mattila A-L, Perheentupa J, Pesonen K, Viinikka L. Epidermal growth factor in human urine from birth to puberty. J Clin Endocrinol Metab 1985; 61: 997-1000.
105. Mattila A-L, Viinikka L, Saario I, Perheentupa J. Human epidermal growth factor: renal production and absence from plasma. Regul Pept 1988; 23: 89-93.
106. Mellon K, Wright C, Kelly P, Home CHW, Neal DE. Bladder cancer, long-term outcome related to epidermal growth factor receptor status in bladder cancer. J Urol 1995; 153: 919-925.
107. Messing EM. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. Cancer Res 1990; 50: 2530-2537.
108. Messing EM, Murphy-Brooks N. Recovery of epidermal growth factor in voided urine of patients with bladder cancer. Urology 1994; 44: 502-506.
109. Messing EM, Reznikoff CA. Normal and malignant human urothelium: in vitro effects of epidermal growth factor. Cancer Res 1987; 47: 2230-2235.
110. Miller SB, Rogers SA, Estes CE, Hammerman MR. Increased distal nephron EGF content and altered distribution of peptide in compensatory renal hypertrophy. Am J Physiol 1992; 262: F1032-F1038.
111. Morin NJ, Laurent G, Nonclercq D, Toubeau G, Heuson-Stiennon J-A. Bergeron MG, Beauchamp D. Epidermal growth factor accelerates renal tissue repair in a model of gentamicin nephrotoxicity in rats. Am J Physiol 1992; 263: F806-F811.
112. Mount CD, Lukas TJ, Orth DN. Characterization of a high-molecular-weight form of epidermal growth factor in an extract of human urine. Arch Biochem Biophys 1987; 255: 1-7.
113. Mount CD, Lukas TJ, Orth DN. Purification and characterization of epidermal growth factor (β-urogastrone) and epidermal growth factor fragments from large volumes of human urine. Arch Biochem Biophys 1985; 240: 33-42.
114. Mroczkowski B, Reich M. Identification of biologically active epidermal growth factor precursor in human fluids and secretions. Endocrinology 1993; 132: 417-425.
115. Murakami T, Kishimoto M, Higashi Y, Amagase H, Hayashi T, Fuwa T, Yata N. Biliary and urinary excretions of immunoreactive human epidermal growth factor after intravenous administration in rats. Int J Pharmaceutics 1989; 49: 173-178.
116. Mydlo JH, Michaeli J, Cordon-Cardo C, Goldenberg AS, Heston WDW, Fair WR. Expression of transforming growth factor a and epidermal growth factor receptor messenger RNA in neoplastic and non-neoplastic human kidney tissue. Cancer Res 1989; 49: 3407-3411.
117. Neal DE, Mellon K. Epidermal growth factor receptor and bladder cancer: a review. Urol Int 1992; 48: 365-371.
118. Nexø E. Epidermal growth factor-familien. Ugeskr Lsger 1994; 156: 6670-6675.
119. Nexø E, Hansen HF. Binding of epidermal growth factor from man, rat and mouse to the human epidermal growth factor receptor. Biochim Biophys Acta 1985; 843: 101-106.
120. Nexø, E, Hollenberg MD, Bing J. Aggressive behaviour in mice provokes a marked increase in both plasma epidermal growth factor and renin. Acta Physiol Scand 1981; 111: 367-371.
121. Nexø E, Jørgensen PE, Hansen MR. Human epidermal growth factor-on molecular forms present in urine and blood. Regul Pept 1992; 42: 75-84.
122. Nexø E, Lamberg SI, Hollenberg MD. Comparison of a receptor binding assay with a radioimmunoassay for measuring human epidermal growth factor- urogastrone in urine. Scand J Clin Lab Invest 1981; 41: 577-582.
123. Nexø E, Nexø B. Construction and use of a RIA-gram. Scand J Clin Lab Invest 1989; 49, Suppl. 194: 27-33.
124. Nexø E, Olsen PS, Poulsen K. Exocrine and endocrine secretion of renin and epidermal growth factor from the mouse submandibular glands. Regul Pept 1984; 8: 327-334.
125. Nexø E, Poulsen SS, Hansen SN, Kirkegaard P, Olsen PS. Characterisation of a novel proteolytic enzyme localized to goblet cells in rat and man. Gut 1984; 25: 656-664.
126. Nguyen PL, Swanson PE, Jaszcz W, Aeppli DM, Zhang G, Singleton TP, Ward S, Dykoski D, Harvey J, Niehans GA. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder, a multivariate survival anlysis. Am J Clin Pathol 1994; 101: 166-176.
127. Nielsen S, Nexø E, Christensen EI. Absorption of epidermal growth factor and insulin in rabbit renal proximal tubules. Am J Physiol 1989; 256: E55-E63.
128. Norman J, Badie-Dezfooly B, Nord EP, Kurtz I, Schlosser J, Chaudhari A, Fine LG. EGF-induced mitogenesis in proximal tubular cells: potentiation by angiotensin II. Am J Physiol 1987; 253: F299-F309.
129. Norman J, Tsau Y-K, Bacay A, Fine LG. Epidermal growth factor accelerates functional recovery from ischaemic acute tubular necrosis in the rat: role of the epidermal growth factor receptor. Clin Sci 1990; 78: 445-450.
130. Nouwen EJ, De Broe ME. EGF and TGF-α in the human kidney: identification of octopal cells in the collecting duct. Kidney Int 1994; 45: 1510-1521.
131. Nouwen EJ, Verstrepen WA, Buyssens N, Zhu M-Q, De Broe ME. Hyperplasia, hypertrophy, and phenotypic alterations in the distal nephron after acute proximal tubular injury in the rat. Lab Invest 1994; 70: 479-493.
132. Nustad K, Pierce JV. Purification of rat urinary kallikreins and their specific antibody. Biochemistry 1974; 13: 2312-2319.
133. Oka Y, Orth DN. Human plasma epidermal growth factor/β-urogastrone is associated with blood platelets. J Clin Invest 1983; 72: 249-259.
134. Olsen PS, Kirkegaard P, Poulsen SS, Nexø E. Adrenergic effects on exocrine secretion of rat submandibular epidermal growth factor. Gut 1984; 25: 1234-1240.
135. Olsen PS, Kirkegaard P, Poulsen SS, Nexø E. Adrenergic effects on renal secretion of epidermal growth factor in the rat. Regul Pept 1985; 11: 17-25.
136. Olsen PS, Kirkegaard P, Poulsen SS, Nexø E. Vasoactive intestinal polypeptide and acetylcholine stimulate exocrine secretion of epidermal growth factor from the rat submandibular gland. Regul Pept 1986; 15: 37-46.
137. Olsen PS, Nexø E, Poulsen SS, Hansen HF, Kirkegaard P. Renal origin of rat urinary epidermal growth factor. Regul Pept 1984: 10; 37-45.
138. Olsen PS, Poulsen SS, Kirkegaard P, Nexø E. Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology 1984; 87: 103-108.
139. Ørstavik TB. The distribution and secretion of kallikrein in some exocrine organs of the rat. Acta Physiol Scand 1978; 104: 431-442.
140. Ørstavik TB, Brandtzaeg P, Nustad K, Halvorsen KM. Cellular localization of kallikreins in rat submandibular and sublingual salivary glands, immunoflourescence tracing related to histological characteristics. Acta Histochem 1975; 54: 183-192.
141. Ørstavik TB, Carretero OA, Hayashi H, Scicli GA, Johansen L. Immunohistochemical localization of tonin and its relation to kallikrein in rat salivary glands. J Histochem Cytochem 1982; 30: 1123-1129.
142. Ørstavik TB, Gautvik KM. Regulation of salivary kallikrein secretion in the rat submandibular gland. Acta Physiol Scand 1977; 100: 33-44.
143. Ørslavik TB, Inagami T. Localization of kallikrein in the rat kidney and its anatomical relationship to renin. J Histochem Cytochem 1982; 30: 385-390.
144. Otani N, Tsukamoto T, Masumori N, Saiki I, Yoneda J, Kumamoto Y. Influence of growth factors on in vitro invasiveness and type IV colla-genolysis of human renal cell carcinoma cells. J Urol 1994; 151: 223-226.
145. Oyasu R, Hirao Y, Izumi K. Enhancement by urine of urinary bladder carcinogenesis. Cancer Res 1981; 41: 478-481.
146. Pascall JC, Jones DSC, Doel SM, Clements JM, Hunter M, Fallon T, Edwards M, Brown KD. Cloning and characterization of a gene encoding pig epidermal growth factor. J Mol Endocrin 1991; 6: 63-70.
147. Pesonen K, Viinikka L, Koskimies A, Banks AR, Nicolson M, Perheentupa J. Size heterogeneity of epidermal growth factor in human body fluids. Life Sci 1987; 40: 2489-2494.
148. Peters G. Compensatory adaption of renal functions in the unanesthetized rat. Am J Physiol 1963; 205: 1042-1048.
149. Petrides PE, Bock S, Bovens J, Hofmann R, Jakse G. Modulation of pro-epidermal growth factor, pro-transforming growth factor α and epidermal growth factor receptor gene expression in human renal carcinomas. Cancer Res 1990; 50: 3934-3939.
150. Playford RJ, Woodman AC, Clark P, Watanapa P, Vesey D, Deprez PH, Williamson RCN, Calam J. Effect of luminal growth factor preservation on intestinal growth. Lancet 1993; 341: 843-848.
151. Plowman GD, Green JM, McDonald VL, Neubauer MG, Disteche CM, Todaro GJ, Shoyab M. The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol Cell Biol 1990; 10: 1969-1981.
152. Poulsen SS, Nexø E, Olsen PS, Hess J, Kirkegaard P. Immunohistochemical localization of epidermal growth factor in rat and man. Histochemistry 1986; 85: 389-394.
153. Prigent SA, Lemoine NR. The type 1 (EGFR-related) family of growth factor receptors and their ligands. Progress Growth Factor Res 1992; 4: 1-24.
154. Quigley R, Baum M. Effects of epidermal growth factor and transforming growth factor-α on rabbit proximal tubule solute transport. Am J Physiol 1994; 266: F459-F465.
155. Rall LB, Scott J, Bell GI, Crawford RJ, Penschow JD, Niall HD, Coghlan JP. Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature 1985; 313: 228-231.
156. Rao RK, Koldovsky O, Korc M, Pollack PF, Wright S, Davis TP. Processing and transfer of epidermal growth factor in developing rat jejunum and ileum. Peptides 1990; 11: 1093-1102.
157. Reiss R, Funke AJ, Cieslinski DA, Humes HD. Transforming growth factor-alpha (TGFα) accelerates renal repair and recovery following ischemic injury to the kidney. Kidney Int 1990; 37: 492 (abstr).
158. Rogers SA, Hammerman MR. Epidermal growth factor binding and stimulation of inositol triphosphate production in basolateral membranes from dog kidney. Biochem Biophys Res Commun 1993; 191: 1319-1325.
159. Rogers SA, Rasmussen J, Miller SB, Hammerman MR. Effects of growth hormone on rat renal epidermal growth factor expression. Am J Physiol 1994; 267: F208-F214.
160. Sack EM, Arruda JAL. Epidermal growth factor binding to cortical basolateral membranes in compensatory renal hypertrophy. Regul Pept 1991; 33: 339-348.
161. Sack E, Talor Z. High affinity binding sites for epidermal growth factor (EGF) in renal membranes. Biochem Biophys Res Commun 1988; 154: 312-317.
162. Safirstein R, Price PM, Saggi SJ, Harris RC. Changes in gene expression after temporary renal ischemia. Kidney Int 1990; 37: 1515-1521.
163. Safirstein R, Zelent AZ, Price PM. Reduced renal prepro-epidermal growth factor mRNA and decreased EGF excretion in ARF. Kidney Int 1989; 36: 810-815.
164. Saggi SJ, Safirstein R, Price PM. Cloning and sequencing of the rat prepro-epidermal growth factor cDNA: comparison with mouse and human sequences. DNA Cell Biol 1992; 11: 481-487.
165. Salido EC, Barajas L, Lechago J, Laborde NP, Fisher DA. Immunocytochemical localization of epidermal growth factor in mouse kidney. J Histochem Cytochern 1986; 34: 1155-1160.
166. Salido EC, Fisher DA, Barajas L. Immunoelectron microscopy of epidermal growth factor in mouse kidney. J Ultrastruc Mol Struc Res 1986; 96; 105-113.
167. Salido EC, Lakshmanan J, Fisher DA, Barajas L. Immunocytochemical localization of epidermal growth factor prohormone in adult human kidney. Clin Res 1991; 39: 112A (abstr).
168. Salido EC, Lakshmanan J, Fisher DA, Shapiro LJ, Barajas L. Expression of epidermal growth factor in the rat kidney, an immunocytochemical and in situ hybridization study. Histochemistry 1991; 96: 65-72.
169. Salido EC, Lakshmanan J, Yen P, Barajas L, Shapiro LJ, Fisher DA. Epidermal growth factor precursor processed peptides are colocalized in adult mouse tissues that express pro-EGF inRNA. Clin Res 1990; 38: 174A (abstr).
170. Salido EC, Yen PH, Shapiro LJ, Fisher DA, Barajas L. In situ hybridization of prepro-epidermal growth factor mRNA in the mouse kidney. Am J Physiol 1989; 256: F632-F638.
171. Sargent ER, Gomella LG, Belldegrun A, Linehan WM, Kasid A. Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma. J Urol 1989; 142: 1364-1368.
172. Sasada R, Ono Y, Taniyama Y, Shing Y, Folkman J, Igarashi K. Cloning and expression of cDNA encoding human betacellulin, a new member of the EGF family. Biochem Biophys Res Commun 1993; 190: 1173-1179.
173. Savage Jr CR, Hash JH, Cohen S. Epidermal growth factor, location of disulfide bonds. J Biol Chem 1973; 248: 7669-7672.
174. Savage Jr CR, Inagami T, Cohen S. The primary structure of epidermal growth factor. J Biol Chem 1972; 247: 7612-7621.
175. Scardovi C, De Felice GP, Gazzaniga A. Epidermal growth factor in the topical treatment of traumatic corneal ulcers. Ophthalmologica 1993; 206: 119-124.
176. Schaudies RP, Johnson JP. Increased soluble EGF after ischemia is accompanied by a decrease in membrane-associated precursors. Am J Physiol 1993; 264: F523-F531.
177. Schaudies RP, Nonclercq D, Nelson L, Toubeau G, Zanen J, Heuson-Stien-non J-A, Laurent G. Endogenous EGF as a potential renotrophic factor in ishemia-induced acute renal failure. Am J Physiol 1993; 265: F425-F434.
178. Schlessinger J, Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron 1992; 9: 383-391.
179. Scoggins BA, Butkus A, Coghlan JP, Fei DTW, McDougall JG, Niall HD, Walsh JR, Wang X. In vivo cardiovascular, renal and endocrine effects of epidermal growth factor in sheep. In Labrie F, Proulx L (Eds), Endocrinology, Elsevier, Amsterdam 1984: 573-576.
180. Scott J, Urdea M, Quiroga M, Sanchez-Pescador R, Fong N, Selby M, Rutter
181. Shing Y, Christofori G, Hanahan D, Ono Y, Sasada R, Igarashi K, Folkman J. Betacellulin: a mitogen from pancreatic β cell tumors. Science 1993; 259: 1604-1607.
182. Shoyab M, McDonald VL, Bradley JG, Todaro GJ. Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. Proc Natl Acad Sci USA 1988; 85: 6528-6532.
183. Simpson RJ, Smith JA, Moritz RL, OHare MJ, Rudland PS, Morrison JR, Lloyd CJ, Grego B, Burgess AW, Nice EC. Rat epidermal growth factor: complete amino acid sequence, homology with the corresponding murine and human proteins; isolation of a form truncated at both ends with full in vitro biological activity. Eur J Biochem 1985; 153: 629-637.
184. St Hilaire RJ, Hradek GT, Jones AL. Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a high-capacity uptake system. Proc Natl Acad Sci USA 1983; 80: 3797-3801.
185. Stoll DM, King Jr LE, McNeil L, Orth DN. Human urinary epidermal growth factor excretion: age, sex, and race dependence. J Clin Endocrinol Metab 1988; 67: 361-367.
186. Taub M, Wang Y, Szczesny TM, Kleinman HK. Epidermal growth factor or transforming growth factor a is required for kidney tubulogenesis in matrigel cultures in serum-free medium. Proc Natl Acad Sci USA 1990; 87: 4002-4006.
187. Taylor JM, Mitchell WM, Cohen S. Characterization of the binding protein for epidermal growth factor. J Biol Chem 1974; 249: 2188-2194.
188. Theuer CP, Fitzgerald DJ, Pastan I. A recombinant form of pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer. J Urol 1993; 149: 1626-1632.
189. Thibault G, Genest J. Tonin, an esteroprotease from rat submaxillary glands. Biochim Biophys Acta 1981; 660: 23-29.
190. Tobeau G, Nonclercq D, Zanen J, Lambricht P, Tulkens PM, Heuson-Stiennon J-A, Laurent G. Distribution of epidermal growth factor in the kidney of rats exposed to amikacin. Kidney Int 1991; 40: 691-699.
191. Tsukumo K, Nakamura H, Sakamoto S. Purification and characterization of high molecular weight human epidermal growth factor from human urine. Biochem Biophys Res Commun 1987; 145: 126-133.
192. Vaughan TJ, Pascall JC, Brown KD. Tissue distribution of mRNA for heparin-binding epidermal growth factor. Biochem J 1992; 287: 681-684.
193. Vehaskari VM, Hering-Smith KS, Moskowitz DW, Weiner ID, Hamm LL. Effect of epidermal growth factor on sodium transport in the cortical collecting tubule. Am J Physiol 1989; 256: F803-F809.
194. 131I-labelled epidermal growth factor in the pig visualized by dynamic scintigraphy. J Endocrinol 1995; 144: 5-12.
195. Vinter-Jensen L, Juhl CO, Djurhuus JC, Poulsen SS, Dajani EZ, Brown KD, Ørntoft TF, Teglbærg PS, Nexø E. Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates. Am J Pathol 1995; 147: 1330-1338.
196. Vinter-Jensen L, Smerup M, Jørgensen PE, Juhl CO, Ørntoft T, Poulsen SS, Nexø E. Chronic treatment with epidermal growth factor stimulates growth of the urinary tract in the rat. Urol Res 1996; 24: 15-21.
197. Walker C, Everitt J, Freed JJ, Knudson Jr AG, Whiteley LO. Altered expression of transforming growth factor-α in hereditary rat renal cell carcinoma. Cancer Res 1991; 51: 2973-2978.
198. Walton GM, Chen WS, Rosenfeld MG, Gill, GN. Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates. J Biol Chem 1990; 265: 1750-1754.
199. Wilson PD, Jing D, Norman JT. Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease. Eur J Cell Biol 1993; 61: 131-138.
200. Yarden Y, Schlessinger J. Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry 1987; 26: 1434-1442.
201. Yoshida K, Tosaka A, Takeuchi S, Kobayashi N. Epidermal growth factor receptor content in human renal cell carcinomas. Cancer 1994; 73: 1913-1918.
202. Yura Y, Hayashi O, Kelly M, Oyasu R. Identification of epidermal growth factor as a component of the rat urinary bladder tumor-enhancing urinary fractions. Cancer Res 1989; 49: 1548-1553.
203. Yussim A, Lev-Ran A, Hwang DL, Shapira Z. Epidermal growth factor in urine and serum after living donor kidney transplantation. Transplant Proc 1995; 27: 1048-1049.
204. Zhou M, Felder S, Rubinstein M, Hurwitz DR, Ullrich A, Lax I, Schlessinger J. Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation. Biochemistry 1993; 32: 8193-8198.